142 related articles for article (PubMed ID: 6335607)
1. Apparent intrinsic prothrombinase activity of human Factor X zymogen: identification with Factor VIII inhibitor bypassing activity (FEIBA).
Estry DW; Tishkoff GH
Thromb Res; 1984 Dec; 36(6):549-62. PubMed ID: 6335607
[TBL] [Abstract][Full Text] [Related]
2. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
[TBL] [Abstract][Full Text] [Related]
3. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
[TBL] [Abstract][Full Text] [Related]
4. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
[TBL] [Abstract][Full Text] [Related]
5. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
[TBL] [Abstract][Full Text] [Related]
6. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
Ahmad SS; Walsh PN
Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
[TBL] [Abstract][Full Text] [Related]
7. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.
Hertzberg MS; Ben-Tal O; Furie B; Furie BC
J Biol Chem; 1992 Jul; 267(21):14759-66. PubMed ID: 1634519
[TBL] [Abstract][Full Text] [Related]
8. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
9. Comparison between two concentrates with factor VIII inhibitor bypassing activity.
Vinazzer H
Thromb Res; 1982 Apr; 26(1):21-9. PubMed ID: 6980497
[TBL] [Abstract][Full Text] [Related]
10. An inhibitory monoclonal antibody to factor X that blocks prothrombin activation but not prothrombinase enzyme assembly.
Church WR; Messier TL; Tucker MM; Mann KG
Blood; 1988 Dec; 72(6):1911-21. PubMed ID: 2461754
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant mechanism of factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
Ishikawa M; Kumashiro M; Yamazaki Y; Atoda H; Morita T
J Biochem; 2009 Jan; 145(1):123-8. PubMed ID: 18977769
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of inhibition of platelet coagulant activity.
Ellis V; Scully MF; Kakkar VV
Adv Exp Med Biol; 1985; 192():373-87. PubMed ID: 2422887
[TBL] [Abstract][Full Text] [Related]
13. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.
Pieters J; Willems G; Hemker HC; Lindhout T
J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615
[TBL] [Abstract][Full Text] [Related]
15. Zymogen factor IX potentiates factor IXa-catalyzed factor X activation.
London FS; Walsh PN
Biochemistry; 2000 Aug; 39(32):9850-8. PubMed ID: 10933803
[TBL] [Abstract][Full Text] [Related]
16. Platelet procoagulant complex assembly in a tissue factor-initiated system.
Monroe DM; Roberts HR; Hoffman M
Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
[TBL] [Abstract][Full Text] [Related]
17. The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.
Mertens K; Bertina RM
Biochem J; 1984 Nov; 223(3):607-15. PubMed ID: 6334517
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prothrombinase complex by plasma proteinase inhibitors.
Ellis V; Scully MF; Kakkar VV
Biochemistry; 1984 Nov; 23(24):5882-7. PubMed ID: 6335402
[TBL] [Abstract][Full Text] [Related]
19. The role of blood clotting factor V in the conversion of prothrombin and a decarboxy prothrombin into thrombin.
Vermeer C; Govers-Riemslag JW; Soute BA; Lindhout MJ; Kop J; Hemker HC
Biochim Biophys Acta; 1978 Feb; 538(3):521-33. PubMed ID: 564211
[TBL] [Abstract][Full Text] [Related]
20. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
